ATM and Huntington disease: A recent study highlighting the importance of DNA damage in neurodegenerative disorders has shown that either genetic or pharmacological ablation of DDR kinase ATM activity significantly ameliorates neurotoxicity in HD animal models (Lu et al., 2014).